Staats, L.A.N.; Pfeiffer, H.; Knopf, J.; Lindemann, A.; Fürst, J.; Kremer, A.E.; Hackstein, H.; Neurath, M.F.; Muñoz, L.E.; Achenbach, S.;
et al. IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients. Cells 2020, 9, 2676.
https://doi.org/10.3390/cells9122676
AMA Style
Staats LAN, Pfeiffer H, Knopf J, Lindemann A, Fürst J, Kremer AE, Hackstein H, Neurath MF, Muñoz LE, Achenbach S,
et al. IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients. Cells. 2020; 9(12):2676.
https://doi.org/10.3390/cells9122676
Chicago/Turabian Style
Staats, Léonie A. N., Hella Pfeiffer, Jasmin Knopf, Aylin Lindemann, Julia Fürst, Andreas E. Kremer, Holger Hackstein, Markus F. Neurath, Luis E. Muñoz, Susanne Achenbach,
and et al. 2020. "IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients" Cells 9, no. 12: 2676.
https://doi.org/10.3390/cells9122676
APA Style
Staats, L. A. N., Pfeiffer, H., Knopf, J., Lindemann, A., Fürst, J., Kremer, A. E., Hackstein, H., Neurath, M. F., Muñoz, L. E., Achenbach, S., Leppkes, M., Herrmann, M., Schett, G., & Steffen, U.
(2020). IgA2 Antibodies against SARS-CoV-2 Correlate with NET Formation and Fatal Outcome in Severely Diseased COVID-19 Patients. Cells, 9(12), 2676.
https://doi.org/10.3390/cells9122676
